ScoreWhy is Champions Oncology, Inc. ?
1
Negative results in Jan 26
- PRE-TAX PROFIT(Q) At USD -0.24 MM has Fallen at -140.22%
- NET PROFIT(Q) At USD -0.28 MM has Fallen at -144.78%
- RAW MATERIAL COST(Y) Grown by 24.62% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -20.76%, its profits have fallen by -136.4%
3
Below par performance in long term as well as near term
- Along with generating -20.76% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Champions Oncology, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Champions Oncology, Inc.
-20.76%
0.18
64.36%
S&P 500
21.51%
1.63
13.19%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.11%
EBIT Growth (5y)
-184.86%
EBIT to Interest (avg)
-1.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
5.45
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
43.24%
ROCE (avg)
40.85%
ROE (avg)
24.39%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.61
EV to EBIT
-33.37
EV to EBITDA
-74.19
EV to Capital Employed
-59.98
EV to Sales
1.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-54.70%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 4.39 MM
-16What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -0.24 MM has Fallen at -140.22%
NET PROFIT(Q)
At USD -0.28 MM has Fallen at -144.78%
RAW MATERIAL COST(Y)
Grown by 24.62% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.16 times
Here's what is working for Champions Oncology, Inc.
Operating Cash Flow
Highest at USD 4.39 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Champions Oncology, Inc.
Pre-Tax Profit
At USD -0.24 MM has Fallen at -140.22%
over average net sales of the previous four periods of USD 0.59 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -0.28 MM has Fallen at -144.78%
over average net sales of the previous four periods of USD 0.62 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 4.16 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 24.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
